Abstract Background: The health care industry is witnessing an increasing trend in the use of generic medicines because of their presumed low cost compared with innovator medicines.
← all excerpts
Deferasirox in thalassemia: a comparative study between an innovator drug and its copy among a sample of Iraqi patients.
1
—
—